Last reviewed · How we verify

NCT03426241

Effect of Smoking on the Expression of Gelatinases in Chronic Periodontitis

Completed Last updated 8 February 2018
What this trial tests

trial testing no intervention in Periodontitis in 80 participants. Completed in 30 December 2012.

Timeline
10 February 2010
Primary endpoint
29 December 2012
30 December 2012

Quick facts

Lead sponsorBaskent University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment80
Start date10 February 2010
Primary completion29 December 2012
Estimated completion30 December 2012

Drugs / interventions tested

Conditions studied

Sponsor

Baskent University

Who can join

Adults 16 to 62, any sex, with Periodontitis or Smoking. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study comparatively evaluate the expressions of MMP-2 and MMP-9 in smoker vs non-smoker chronic periodontitis patients as well as periodontally healthy subjects. the hypothesis of this study was that smoking may interfere with periodontal disease by effecting MMP-2 and MMP-9 expressions.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of no intervention

Trials testing the same drug.

Other recruiting trials for Periodontitis

Currently open trials in the same condition.

Other Baskent University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03426241.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing